# Magnesium Glycinate Insomnia Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/magnesium-glycinate-insomnia-meta-analysis-evidence-review
Category: evidence-review
Summary: Magnesium Glycinate Insomnia Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass 
Last reviewed: 2026-06-24
Reviewed by: Migaku Evidence Review
# Magnesium Glycinate Insomnia Meta-analysis: What the Evidence Says

## Quick Answer

Magnesium Glycinate Insomnia Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Magnesium - The Silent Partner or the Next Vitamin D? Shifting Paradigm in Mineral Metabolism in Health and Disease | research article | 4 | 2026-02-02 | PMC12882071 |
| The Mechanisms of Magnesium in Sleep Disorders. | research article | 4 | 2025-10-15 | 10.2147/nss.s552646 |

## What The Sources Report

- Despite its significance, standard serum magnesium testing is unreliable; patients may have normal serum levels of 0.75-0.95 mmol/L yet present with evidence of chronic, underlying deficiency. [Ahmed Sibtain (2026); evidence level 4]
- Evidence suggests that up to 42% of young adults exhibit undetected insufficiency and nearly half of the US population fails to meet the RDA of 300-400 mg/day. [Ahmed Sibtain (2026); evidence level 4]
- Additionally, magnesium supplements can improve sleep parameters in a variety of sleep-related diseases, especially those associated with the occurrence and development of sleep disorders. [He C (2025); evidence level 4]
- Sleep is a highly elaborate biological occurrence, necessitating the combined action and participation of diverse brain regions. [He C (2025); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For magnesium glycinate insomnia meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Ahmed Sibtain (2026). Magnesium - The Silent Partner or the Next Vitamin D? Shifting Paradigm in Mineral Metabolism in Health and Disease. PMCID: PMC12882071. PMID: 41659294. License: https://creativecommons.org/licenses/by-nc/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC12882071/
- He C (2025). The Mechanisms of Magnesium in Sleep Disorders.. DOI: 10.2147/nss.s552646. PMCID: PMC12535714. PMID: 41116797. https://pmc.ncbi.nlm.nih.gov/articles/PMC12535714/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.